Trials / Not Yet Recruiting
Not Yet RecruitingNCT07431762
Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,058 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This trial is a multinational, multicenter, randomized, open-label, active-controlled clinical trial comparing the safety of aspirin versus vitamin K antagonists (warfarin) as oral antithrombotic therapy during the initial 6 months following tissue valve replacement (aortic or mitral).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin | 100mg 1 tablet once daily for 6 months |
| DRUG | Vitamin K antagonist(warfarin) | Maintain an INR of 2.0 to 3.0 for 6 months |
Timeline
- Start date
- 2026-02-01
- Primary completion
- 2030-10-31
- Completion
- 2031-03-31
- First posted
- 2026-02-25
- Last updated
- 2026-02-25
Locations
3 sites across 2 countries: Japan, South Korea
Source: ClinicalTrials.gov record NCT07431762. Inclusion in this directory is not an endorsement.